How should acute orchitis be treated, including supportive care and age‑specific antibiotic selection?

Acute Orchitis Management

Immediate Priority: Exclude Testicular Torsion

Before initiating any treatment for suspected orchitis, testicular torsion must be ruled out immediately, as testicular viability is lost within 6-8 hours of symptom onset. 1

• Torsion presents with abrupt onset of severe pain, absent urinary symptoms, and negative urinalysis, whereas orchitis typically shows gradual onset over hours to days with inflammatory symptoms 1
• If clinical suspicion for torsion is high, proceed directly to surgical exploration without waiting for imaging 1
• The cremasteric reflex is typically intact in orchitis but absent in torsion 2

Age-Stratified Empiric Antibiotic Therapy

For Patients Under 35 Years

Initiate ceftriaxone 1 g IM/IV single dose PLUS doxycycline 100 mg orally twice daily for 10 days immediately upon diagnosis. 3, 4, 1

• This dual therapy targets Chlamydia trachomatis and Neisseria gonorrhoeae, the predominant pathogens in sexually active men aged 14-35 years 4, 1, 2
• Single-agent therapy (e.g., fluoroquinolone alone) is inadequate and represents a critical pitfall, as it fails to cover both organisms 4

For Patients 35 Years or Older

Prescribe either ofloxacin 300 mg orally twice daily for 10 days OR levofloxacin 500 mg orally once daily for 10 days. 3, 4

• These fluoroquinolones target enteric gram-negative bacteria, particularly Escherichia coli, which predominate in older men 4, 2
• Consider local quinolone resistance patterns, especially if infection was acquired in Asia or Pacific regions 3

Risk Factors Favoring Enteric Pathogens (Use Fluoroquinolone Regimen)

• Age ≥35 years, recent urinary instrumentation, urinary tract anomalies, benign prostatic hyperplasia, or receptive anal intercourse 4

Essential Diagnostic Workup (Obtain Before Starting Antibiotics)

• Urethral Gram stain to detect urethritis (≥5 polymorphonuclear leukocytes per high-power field) and presumptively diagnose gonorrhea 4, 1
• Nucleic acid amplification test (NAAT) from urethral swab or first-void urine for N. gonorrhoeae and C. trachomatis 3, 4, 1
• Urinalysis and urine culture with antibiogram to guide therapeutic adjustments 4, 1
• Syphilis serology and HIV testing as part of comprehensive STI screening 4, 1

Supportive Care Measures

Prescribe bed rest, scrotal elevation, and analgesics (NSAIDs preferred for anti-inflammatory effect) until fever and local inflammation resolve. 3, 4, 1

• Scrotal support or athletic supporter reduces edema and discomfort 4
• Patients must abstain from sexual intercourse until therapy is completed and symptoms have resolved 3, 4

Mandatory Follow-Up and Reassessment

Re-evaluate the patient at 48-72 hours; if no clinical improvement is observed, reassess both the diagnosis and antibiotic regimen. 4, 1, 5

• Expected response includes reduction in pain, swelling, and tenderness within 3 days 4
• Failure to improve warrants consideration of alternative diagnoses: testicular tumor, abscess formation, testicular infarction, fungal infection, or Streptococcus intermedius abscess 3, 4
• Obtain scrotal ultrasound if diagnosis is uncertain or complications are suspected 4, 6

Surgical Intervention Criteria

Immediate surgical consultation and drainage are required if there is failure to improve within 3 days of appropriate antibiotic therapy. 3

• Ultrasound findings of abscess, pyocele, or testicular infarction mandate surgical evaluation 5, 6
• Patients with palpable malacia, inability to differentiate epididymis from testis, or multiple abscesses typically require organ-sparing surgery 5

Management of Sexual Partners

All sexual partners who had contact within 60 days preceding symptom onset must be referred for evaluation and empiric treatment covering both N. gonorrhoeae and C. trachomatis. 3, 4, 1

• Partners receive dual therapy regardless of the index patient's identified pathogen 4
• Repeat syphilis and HIV testing at 6 weeks, 3 months, and 6 months if initial results are negative 1

Special Populations and Considerations

Mumps Orchitis (Viral)

• Ask specifically about parotid gland swelling in the preceding 10 days, as mumps orchitis occurs in up to 38% of postpubertal males with mumps infection 1
• Treatment is supportive; some evidence suggests interferon-alpha 2a may reduce testicular atrophy risk, though this is not standard practice 7, 8

HIV-Positive or Immunocompromised Patients

• Treat with the same antibiotic regimens as immunocompetent patients 3
• Maintain higher suspicion for atypical organisms including fungal and mycobacterial causes 4

Adolescents

• Confidential screening for sexual assault is essential; provide prophylactic STI treatment if assault occurred, even without symptoms 1

Common Pitfalls to Avoid

• Delaying torsion evaluation: Any acute scrotal pain requires immediate assessment for torsion before attributing symptoms to infection 1
• Monotherapy in young men: Fluoroquinolone alone misses chlamydial coverage; dual therapy is mandatory 4
• Relying solely on urinalysis: STI-related orchitis in men <35 years often presents without significant pyuria; urethral testing is essential 4
• Inadequate follow-up: Failure to reassess at 72 hours delays recognition of complications or alternative diagnoses 3, 4, 1